title: TCF7L2 is associated with high serum triacylglycerol and differentially expressed in adipose tissue in families with familial combined hyperlipidaemia.
abstract: OBJECTIVE
  Common DNA variants of the transcription factor 7-like 2 gene (TCF7L2) are associated with type 2 diabetes. Familial combined hyperlipidaemia (FCHL) is characterised by hypertriacylglycerolaemia, hypercholesterolaemia, or both. Additionally, disturbances in glucose metabolism are commonly seen in FCHL. Therefore, we hypothesised that TCF7L2 may contribute to the genetic susceptibility for this common dyslipidaemia.
  
  
  METHODS
  We investigated the effect of the TCF7L2 variants, rs7903146 and rs12255372, on FCHL and its component traits triacylglycerol (TG), total cholesterol (TC) and apolipoprotein B (ApoB) in 759 individuals from 55 Mexican families. As a replication sample, 719 individuals from 60 Finnish FCHL families were analysed. We also used quantitative RT-PCR to evaluate the transcript levels of TCF7L2 in 47 subcutaneous fat biopsies from unrelated Mexican FCHL and normolipidaemic participants.
  
  
  RESULTS
  Significant evidence for association was observed for high TG for the T alleles of rs7903146 and rs12255372 (p = 0.005 and p = 0.01) in Mexican FCHL families. No evidence for association was observed for FCHL, TC, ApoB or glucose in Mexicans. When testing rs7903146 and rs12255372 for replication in Finnish FCHL families, these single nucleotide polymorphisms were associated with TG (p = 0.01 and p = 0.007). Furthermore, we observed statistically significant decreases in the mRNA levels (p = 0.0002) of TCF7L2 in FCHL- and TG-affected individuals. TCF7L2 expression was not altered by the SNP genotypes.
  
  
  CONCLUSIONS
  These data show that rs7903146 and rs12255372 are significantly associated with high TG in FCHL families from two different populations. In addition, significantly decreased expression of TCF7L2 was observed in TG- and FCHL-affected individuals.
authors.affiliation: Department of Human Genetics, David Geffen School of Medicine at UCLA, University of California, Los Angeles, CA, USA.
authors.forename: A
authors.initials: A
authors.lastname: Huertas-Vazquez
authors.forename: C
authors.initials: C
authors.lastname: Plaisier
authors.forename: D
authors.initials: D
authors.lastname: Weissglas-Volkov
authors.forename: J
authors.initials: J
authors.lastname: Sinsheimer
authors.forename: S
authors.initials: S
authors.lastname: Canizales-Quinteros
authors.forename: I
authors.initials: I
authors.lastname: Cruz-Bautista
authors.forename: E
authors.initials: E
authors.lastname: Nikkola
authors.forename: M
authors.initials: M
authors.lastname: Herrera-Hernandez
authors.forename: A
authors.initials: A
authors.lastname: Davila-Cervantes
authors.forename: T
authors.initials: T
authors.lastname: Tusie-Luna
authors.forename: M-R
authors.initials: MR
authors.lastname: Taskinen
authors.forename: C
authors.initials: C
authors.lastname: Aguilar-Salinas
authors.forename: P
authors.initials: P
authors.lastname: Pajukanta
mesh_terms: D001055:Apolipoproteins B / Q000378:metabolism; D002784:Cholesterol / Q000378:metabolism; D005192:Family Health; D005260:Female; D005387:Finland; D005786:Gene Expression Regulation; D020022:Genetic Predisposition to Disease; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood* / Q000235:genetics*; D008297:Male; D008800:Mexico; D020641:Polymorphism, Single Nucleotide; D051820:TCF Transcription Factors / Q000235:genetics* / Q000502:physiology*; D058118:Transcription Factor 7-Like 2 Protein; D014280:Triglycerides / Q000097:blood* / Q000378:metabolism
chemical_list: D001055:Apolipoproteins B; D051820:TCF Transcription Factors; C544894:TCF7L2 protein, human; D058118:Transcription Factor 7-Like 2 Protein; D014280:Triglycerides; D002784:Cholesterol